Advertisement
Advertisement
ITOS
ITeos Therapeutics Inc
7.27
USD-0.42
-5.46%
Dec 18, 15:59 UTC -5
Closed
...
ITeos Therapeutics Inc Profile
About
Info & Links
CEO
Michel Detheux
Headquarters
WATERTOWN, MA 02472, UNITED STATES
Industry
Sector
Website
Auditor
Deloitte Bedrijfsrevisoren/R¿viseurs d¿Entreprises BV/SRL
Share holders
210
Employees
157
ITeos Therapeutics Inc Statistics
Valuation Measures
Market Capitalization2
265.57M
Enterprise Value
141.83M
Enterprise Value/EBITDA(ttm)
-0.89
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.44
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
25.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
-5.09%
Return on Equity(ttm)
-20.11%
Return on Invested Capital(ttm)
-20.63%
Return on Assets(ttm)
-17.50%
Income Statement
Revenue(ttm)
35.00M
Revenue Per Share(ttm)
0.96
Gross Profit(ttm)
35.00M
EBITDA(ttm)3
-159.56M
Net Income Available to Common(ttm)
-121.25M
Diluted EPS(ttm)
-3.15
Share Statistics
Beta (5Y Monthly)
1.37
52-Week Change
-28.02%
S&P 500 52-Week Change
23.87%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
36.53M
Dividend Yield
0.00%
Float4
31.97M
% Held by Insiders
12.50%
% Held by Institutions
97.16%
Balance Sheet
Total Cash(mrq)
488.71M
Total Cash Per Share(mrq)
13.38
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
14.80%
Quick Ratio(mrq)
14.80%
Book Value Per Share(mrq)
17.29
Cash Flow
Operating Cash Flow Per Share(ytd)
-2.40
Free Cash Flow(ytd)
-105.16M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement